Rare diseases
Investigational molecules
Locations
Back to Spain330 clinical trials in Salt, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of felzartamab compared to placebo in adults with IgA nephropathy
SpainStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
SpainStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
SpainStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
SpainStudy of visugromab and nivolumab with or without docetaxel as second-line treatment for patients with metastatic non-squamous non-small cell lung cancer
SpainStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer
SpainStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
SpainStudy Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
SpainStudy Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer
SpainStudy on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults
SpainStudy of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer
SpainStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on relapsing-remitting multiple sclerosis and its treatment approaches, including comparative studies of novel therapies and established medications.
Multiple innovative therapies are being evaluated to improve patient outcomes and reduce disease progression.
Dedicated research into Primary Progressive Multiple Sclerosis (PPMS), exploring new therapeutic options through targeted treatment approaches.
Studies focus on developing treatments to delay disability progression in PPMS patients.
Research addressing specific medical conditions including severe primary hand hyperhidrosis and pregnancy-related conditions such as nausea and vomiting.
Clinical investigations aim to enhance treatment options and patient comfort across various conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
